These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

994 related articles for article (PubMed ID: 28154101)

  • 1. Cardioembolic Stroke.
    Kamel H; Healey JS
    Circ Res; 2017 Feb; 120(3):514-526. PubMed ID: 28154101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke Prevention in Atrial Fibrillation: Looking Forward.
    Katsanos AH; Kamel H; Healey JS; Hart RG
    Circulation; 2020 Dec; 142(24):2371-2388. PubMed ID: 33315494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors.
    Verma N; Ziegler PD; Liu S; Passman RS
    Int J Stroke; 2019 Feb; 14(2):146-153. PubMed ID: 30196791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Schnabel RB; Haeusler KG; Healey JS; Freedman B; Boriani G; Brachmann J; Brandes A; Bustamante A; Casadei B; Crijns HJGM; Doehner W; Engström G; Fauchier L; Friberg L; Gladstone DJ; Glotzer TV; Goto S; Hankey GJ; Harbison JA; Hobbs FDR; Johnson LSB; Kamel H; Kirchhof P; Korompoki E; Krieger DW; Lip GYH; Løchen ML; Mairesse GH; Montaner J; Neubeck L; Ntaios G; Piccini JP; Potpara TS; Quinn TJ; Reiffel JA; Ribeiro ALP; Rienstra M; Rosenqvist M; Themistoclakis S; Sinner MF; Svendsen JH; Van Gelder IC; Wachter R; Wijeratne T; Yan B
    Circulation; 2019 Nov; 140(22):1834-1850. PubMed ID: 31765261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    Tomita H; Sasaki S; Hagii J; Metoki N
    J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders.
    Israel C; Kitsiou A; Kalyani M; Deelawar S; Ejangue LE; Rogalewski A; Hagemeister C; Minnerup J; Schäbitz WR
    Thromb Haemost; 2017 Oct; 117(10):1962-1969. PubMed ID: 28862284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
    Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptogenic Stroke: Research and Practice.
    Yaghi S; Bernstein RA; Passman R; Okin PM; Furie KL
    Circ Res; 2017 Feb; 120(3):527-540. PubMed ID: 28154102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source.
    Hawkes MA; Farez MF; Pertierra L; Gomez-Schneider MM; Pastor-Rueda JM; Ameriso SF
    Int J Stroke; 2018 Feb; 13(2):190-194. PubMed ID: 28756759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis and embolism from cardiac chambers and infected valves.
    Adams PC; Cohen M; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):76B-87B. PubMed ID: 3537072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
    Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
    J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Cardiomyopathy: An Emerging Cause of the Embolic Stroke of Undetermined Source.
    Ning Y; Tse G; Luo G; Li G
    Front Cardiovasc Med; 2021; 8():674612. PubMed ID: 34434973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptogenic stroke.
    Fonseca AC; Ferro JM
    Eur J Neurol; 2015 Apr; 22(4):618-23. PubMed ID: 25597418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptogenic Stroke and Embolic Stroke of Undetermined Source: Risk Factors and Approaches for Detection of Atrial Fibrillation.
    Rakhimova I; Semenova Y; Khaibullin T; Kuanysheva A; Kovalchuk V; Abdrakhmanov A
    Curr Cardiol Rev; 2022; 18(4):e211221199213. PubMed ID: 34939547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant?
    Sajeev JK; Kalman JM; Dewey H; Cooke JC; Teh AW
    JACC Clin Electrophysiol; 2020 Mar; 6(3):251-261. PubMed ID: 32192674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study.
    Boriani G; Gallina M; Merlini L; Bonne G; Toniolo D; Amati S; Biffi M; Martignani C; Frabetti L; Bonvicini M; Rapezzi C; Branzi A
    Stroke; 2003 Apr; 34(4):901-8. PubMed ID: 12649505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.